A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2006
11/22/2006	CN1285351C Ointment for treating skin injury and preparation method thereof
11/22/2006	CN1285350C Chinese medicine for treating cold and its preparing method
11/22/2006	CN1285349C Chinese medicinal formulation for treating asthenopia syndrome and its preparation method
11/22/2006	CN1285347C Kuhseng-targeting preparation and its preparing method
11/22/2006	CN1285344C Method for preparing acanthopanax injectio
11/22/2006	CN1285342C Simple prescription of earthworm oral liquid for treating alveolar bone resorption and its preparing method
11/22/2006	CN1285340C Medicine of polysaccharide sulfate amino acid salt, its preparation and application
11/22/2006	CN1285339C Adhesive bandage containing hyaluronic acid biological composition
11/22/2006	CN1285336C Colon-released preparation of Melocicon and beta-cyclodextrin or its derivative composition
11/22/2006	CN1285335C Pyrithioxine hydrochloride freeze-dried composition and its preparing method
11/22/2006	CN1285334C Application of pinocembrin in preparing medication for treating disease relevant to hurt of nerve cell
11/22/2006	CN1285333C Colon target releasing oral preparation and its preparing method
11/22/2006	CN1285332C Ginkgo keto-ester soft capsules with long stable effect and preparation thereof
11/22/2006	CN1285327C Composite product and clothes for scar treatment and method therefor
11/21/2006	US7138546 Compounds and compositions for delivering active agents
11/21/2006	US7138521 Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor
11/21/2006	US7138458 Method for preparing a two-phase water-absorbent bioadhesive composition
11/21/2006	US7138419 Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
11/21/2006	US7138394 Vehicle for topical delivery of anti-inflammatory compounds
11/21/2006	US7138387 Clear aqueous composition comprising propofol and hydroxypropyl-beta-cyclodextrin
11/21/2006	US7138386 Preventives or remedies for arthritis
11/21/2006	US7138385 Thioarabinofuranosyl compounds and use thereof
11/21/2006	US7138382 Compositions and methods for drug delivery using pH sensitive molecules
11/21/2006	US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof
11/21/2006	US7138150 Expressing a nucleic acid encoding protein selected from lactoferrin protein and lysozyme protein in a monocot seed; isolating protein from the seed, combining with carrier diluent to provide formulation for oral administration
11/21/2006	US7138149 aminosaccharide, a ginger component, and an enzyme such as bromelain
11/21/2006	US7138147 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies
11/21/2006	US7138143 Coated preparation soluble in the lower digestive tract
11/21/2006	US7138142 Producing isoleucine, leucine and valine containing particles having reduced bitterness and odor; small volume dose
11/21/2006	US7138141 Atomizing proteins, nucleic acids, or polysaccharides to form microstructure drops used as inhalants; drug delivery
11/21/2006	US7138140 For therapy of allergic diseases, dysuria or pruritus due to kidney dialysis
11/21/2006	US7138139 Film-forming, water soluble polymers that are externally applied to pre-formed tablets
11/21/2006	US7138138 Pharmaceutical formulation having a masked taste and method for the production thereof
11/21/2006	US7138137 Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
11/21/2006	US7138136 Biocompatible particles between 0.1 and 1.0 microns in diameter, that are loaded with one or more drugs and which are crosslinked together to form agglomerates
11/21/2006	US7138135 blend of anionic and nonionic water soluble hydroxyl functionalized polymer; pH insensitivity
11/21/2006	US7138134 Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
11/21/2006	US7138133 Orally administered liquid compositions
11/21/2006	US7138132 Hydrogel entrapping therapeutic agent and stent with coating comprising this
11/21/2006	US7138129 Skin care compositions
11/21/2006	US7138114 Pharmaceutical compositions of fibrinolytic agent
11/21/2006	US7138107 Inhibition of olfactory neurosensory function to treat eating disorders and obesity
11/21/2006	US7138106 Compositions for use in embolizing blood vessels
11/21/2006	US7138105 Compositions for delivery of therapeutics and other materials, and methods of making and using the same
11/21/2006	US7138079 Methods for making foamed elastomer gels
11/21/2006	US7137964 Devices, systems and methods for patient infusion
11/21/2006	CA2478621C Botulinum toxin pharmaceutical compositions
11/21/2006	CA2471494C Delivery system comprising means for controlling internal pressure
11/21/2006	CA2351720C Taste masking rapid release coating system
11/21/2006	CA2338753C Medicinal aerosol formulations
11/21/2006	CA2327693C Use of phospholipids for the manufacture of a medicament for the prevention of adhesions
11/21/2006	CA2318260C Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
11/21/2006	CA2275763C Combatting infection in delivery systems
11/21/2006	CA2253736C Antimicrobial treatment for herpes simplex virus and other infectious diseases
11/21/2006	CA2247611C Method and composition for hair removal
11/21/2006	CA2175122C Release controlled transdermal therapeutic system
11/16/2006	WO2008010784A1 Nanoparticulate and controlled release compositions comprising a cephalosporin
11/16/2006	WO2006122330A2 Implantable pump with infinitely variable resistor
11/16/2006	WO2006122180A2 Disposable fluid container with integrated pump motive assembly
11/16/2006	WO2006122179A2 Fluid container with integrated valve
11/16/2006	WO2006122104A1 Polyethylene glycol colonic purgative composition
11/16/2006	WO2006122075A1 Intravascular filter with drug reservoir
11/16/2006	WO2006122021A1 Extrusion process for making compositions with poorly compressible therapeutic compounds
11/16/2006	WO2006121979A2 Modified-release pharmaceutical compositions
11/16/2006	WO2006121964A2 Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
11/16/2006	WO2006121963A2 Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders
11/16/2006	WO2006121941A2 Pharmaceutical compositions comprising imatinib and a release retardant
11/16/2006	WO2006121819A1 Methods for fabricating nano and microparticles for drug delivery
11/16/2006	WO2006121742A2 Formulations of a src/abl inhibitor
11/16/2006	WO2006121612A1 Treatment of joint disease, methods and apparatuses therefor
11/16/2006	WO2006121199A1 Lipid liposome composition
11/16/2006	WO2006121156A1 Medical composition for promotion of skin regeneration
11/16/2006	WO2006121098A1 Soft capsule film composition
11/16/2006	WO2006120973A1 Gel sheet for protecting skin
11/16/2006	WO2006120851A1 Agent for imparting functions to textile products
11/16/2006	WO2006120705A2 Treatment and control of severe infections including cystic fibrosis
11/16/2006	WO2006120696A2 An improved pharmaceutical composition
11/16/2006	WO2006120623A1 A plaster device
11/16/2006	WO2006120501A1 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
11/16/2006	WO2006120469A2 Therapeutic sclerosing foam made preferably xenon
11/16/2006	WO2006120465A2 Therapeutic sclerosing foam made preferably xenon
11/16/2006	WO2006120461A1 Preparation of therapeutic foam
11/16/2006	WO2006120448A1 Sublingual composition of ifenprodil
11/16/2006	WO2006120412A1 Pharmaceutical formulation of apomorphine for buccal administration
11/16/2006	WO2006120226A1 Stabilizer molecule-depleted albumin solution
11/16/2006	WO2006119968A2 Compositions and methods using microspheres and non-ionic contrast agents
11/16/2006	WO2006119844A2 Controlled release oral drug delivery system
11/16/2006	WO2006119697A1 Xylitol granules capable of directly being pressed into tablets and preparation process thereof
11/16/2006	WO2006119692A1 A medicament for the treatment of hypertension
11/16/2006	WO2006119604A1 Method for preparing and using water-based steroid pheromone compositions
11/16/2006	WO2006119598A2 Transdermal device for the slow delivery of an omega-3-fatty acid, optionally in combination with a hmg coa reductase inhibitor
11/16/2006	WO2006107957A3 Device and methods for treating paranasal sinus conditions
11/16/2006	WO2006087652A3 Soap scent patch and treatment for muscle spasm and pain
11/16/2006	WO2006084914A3 Device for gastric treatment and manufacturing process for the same
11/16/2006	WO2006081517A3 Embolization using poly-4-hydroxybutyrate particles
11/16/2006	WO2006078659A3 Stable prostaglandin-containing compositions
11/16/2006	WO2006074982A3 Two-piece capsule comprising a preliminary closure for accommodating pharmaceutical preparations for powder inhalers
11/16/2006	WO2006060532A3 Formulations of substituted benzoxazoles
11/16/2006	WO2006058247A3 Dosage forms and methods of use thereof
11/16/2006	WO2006055142A8 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane

1 ... 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 ... 2991